1. Home
  2. MUX vs BHVN Comparison

MUX vs BHVN Comparison

Compare MUX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$19.45

Market Cap

1.6B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$8.61

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
BHVN
Founded
1979
2013
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MUX
BHVN
Price
$19.45
$8.61
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$26.63
$28.85
AVG Volume (30 Days)
1.0M
1.8M
Earning Date
03-12-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.52
N/A
Revenue Next Year
$26.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.38
$7.48
52 Week High
$29.70
$29.62

Technical Indicators

Market Signals
Indicator
MUX
BHVN
Relative Strength Index (RSI) 34.24 29.40
Support Level $17.70 $8.40
Resistance Level $20.59 $15.66
Average True Range (ATR) 1.31 0.59
MACD -0.62 -0.12
Stochastic Oscillator 15.48 9.89

Price Performance

Historical Comparison
MUX
BHVN

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: